Creo. 

¥1,302
5
-¥1-0.08% 06:30 Today

Statistics

Day High
1,302
Day Low
1,286
52W High
1,350
52W Low
1,143
Volume
4,300
Avg. Volume
4,165
Mkt Cap
11.18B
P/E Ratio
11.24
Dividend Yield
4.3%
Dividend
55.96

Upcoming

Dividends

4.3%Dividend Yield
Jun 26
¥55
Jun 25
¥51
Jun 24
¥10
Jun 24
¥40
Jun 23
¥40
10Y Growth
27.1%
5Y Growth
7.68%
3Y Growth
11.2%
1Y Growth
7.84%

Earnings

28OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
7.01
24.03
41.05
58.07
Expected EPS
N/A
Actual EPS
N/A

Financials

4.79%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
14.52BRevenue
696MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 9698.TSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Terumo
4543.TSE
Mkt Cap3.46T
Terumo Corporation is a competitor because it also operates in the medical devices sector, focusing on products that compete directly with Creo's offerings in the healthcare market.
Hoya
7741.TSE
Mkt Cap5.32T
HOYA Corporation competes with Creo in the healthcare and medical equipment sector, particularly in areas related to precision medical instruments and devices.
Nintendo
7974.TSE
Mkt Cap6.8T
Nintendo is listed as a competitor due to its involvement in technology and entertainment, though not a direct competitor in medical devices, its broad tech focus places it in competition for investor attention.
Sony Group
6758.TSE
Mkt Cap13.25T
Sony Corporation, while known for its electronics, also has a healthcare division that competes in the medical equipment and device market, making it a competitor to Creo.
Konica Minolta
4902.TSE
Mkt Cap235.5B
Konica Minolta, Inc. competes with Creo through its healthcare segment, offering medical imaging systems and diagnostic equipment that rival Creo's products.
Olympus
7733.TSE
Mkt Cap3.96T
Olympus Corporation is a direct competitor in the medical devices market, specializing in precision machinery and instruments, including endoscopic products that compete with Creo's offerings.
Takeda Pharmaceutical
4502.TSE
Mkt Cap6.05T
Takeda Pharmaceutical Company Limited is a competitor due to its broad involvement in the healthcare sector, including research and development in areas that may overlap with Creo's medical technologies.
Astellas Pharma
4503.TSE
Mkt Cap3.68T
Astellas Pharma Inc. competes in the pharmaceuticals and biotechnology industry, potentially overlapping with Creo's market in terms of medical research and development.
Chugai Pharmaceutical
4519.TSE
Mkt Cap6.03T
Chugai Pharmaceutical Co., Ltd. is involved in the pharmaceuticals sector, competing with Creo in terms of innovation and development in healthcare solutions.
Eisai
4523.TSE
Mkt Cap1.69T
Eisai Co., Ltd. is listed as a competitor because of its focus on pharmaceuticals and healthcare products that may compete with Creo's medical device and technology solutions.

About

Creo Co.,Ltd. operates in Japan, specializing in the development of information processing systems and delivering associated services. Its diverse portfolio encompasses a wide array of solutions, including the CREO integration-platform designed for digital transformation (DX), various cloud-based offerings such as gym cloud, success mark, and N-CLOUD, as well as specialized tools like CREO-RPA, CREO-OCE, BIZ PLATFORM, SmartStage, QuickBinder, and 2Media. Furthermore, Creo provides a comprehensive suite of ZeeM-branded services covering critical business functions. These include ZeeM on Azure, ZeeM HR payroll/TimePro-VG, a school corporation edition for personnel salaries, ZeeM labor and social insurance outsourcing, ZeeM accounting, and ZeeM fixed asset management. Beyond these, the company undertakes commissioned development and constructs essential business systems specifically for local government entities. It also offers specialized human resources solutions like the Veva personnel evaluation system and vital safety confirmation services such as Yahoo! Safety confirmation. Established in 1974, the company initially operated under the name Tokai Create CO., LTD. before officially rebranding as Creo Co.,Ltd. in April 1989. It maintains its headquarters in Tokyo, Japan.
Show more...
CEO
Junichi Kakizaki
Employees
1167
Country
Japan
ISIN
JP3271000006

Listings

0 Comments

Share your thoughts

FAQ

What is Creo. stock price today?
The current price of 9698.TSE is ¥1,302 JPY — it has decreased by -0.08% in the past 24 hours. Watch Creo. stock price performance more closely on the chart.
What is Creo. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Tokyo Stock Exchange exchange Creo. stocks are traded under the ticker 9698.TSE.
Is Creo. stock price growing?
9698.TSE stock has risen by +0.15% compared to the previous week, the month change is a +2.2% rise, over the last year Creo. has showed a +12.05% increase.
What is Creo. market cap?
Today Creo. has the market capitalization of 11.18B
When is the next Creo. earnings date?
Creo. is going to release the next earnings report on October 28, 2026.
What were Creo. earnings last quarter?
9698.TSE earnings for the last quarter are 11.04 JPY per share, whereas the estimation was N/A JPY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is Creo. revenue for the last year?
Creo. revenue for the last year amounts to 14.52B JPY.
What is Creo. net income for the last year?
9698.TSE net income for the last year is 696M JPY.
Does Creo. pay dividends?
Yes, 9698.TSE dividends are paid annual. The last dividend per share was 55 JPY. As of today, Dividend Yield (FWD)% is 4.3%.
How many employees does Creo. have?
As of September 08, 2026, the company has 1,167 employees.
In which sector is Creo. located?
Creo. operates in the Technology sector.
When did Creo. complete a stock split?
Creo. has not had any recent stock splits.
Where is Creo. headquartered?
Creo. is headquartered in Tokyo, Japan.